Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Metoclopramide hydrochloride anhydrous

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 10 USDMF, 4 CEP/COS, 1 JDMF, 3 EU WC, 9 NDC API, 15 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

17 Drugs in Development

17 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

120 FDF Dossiers, 78 FDA Orange Book, 9 Europe, 10 Canada, 4 South Africa, 19 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 5 Evonik, 5 Rochem International Inc, 18 SPI Pharma, 6 DKSH, 5 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 Kirsch Pharma, 4 ACG Worldwide, 6 Actylis, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 17 BASF, 1 CD Formulation, 2 Corel Pharma Chem, 6 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 1 Ideal Cures, 4 Ingredion Pharma Solutions, 15 Kerry, 2 Keval Exports, 3 Lonza Capsugel, 16 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qualicaps, 28 Roquette, 1 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Silverline Chemicals, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

72 Fillers, Diluents & Binders, 41 Direct Compression, 34 Disintegrants & Superdisintegrants, 30 Taste Masking, 28 Granulation, 24 Thickeners and Stabilizers, 21 Chewable & Orodispersible Aids, 20 Parenteral, 19 Film Formers & Plasticizers, 14 Lubricants & Glidants, 12 Co-Processed Excipients, 11 Coating Systems & Additives, 11 Solubilizers, 8 Empty Capsules, 7 Controlled & Modified Release, 6 Topical, 5 Emulsifying Agents, 1 Rheology Modifiers, 1 API Stability Enhancers, 1 Soft Gelatin

DIGITAL CONTENT

2 News #PharmaBuzz

2 News #PharmaBuzz

GLOBAL SALES INFORMATION

13 US Medicaid Prescriptions, 5 Regulatory FDF Prices

MARKET PLACE

12 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

7 US Patents

7 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM

1 EDQM

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	Amsa	Italy	AMSA S.P.A. - ANONIMA MATERIE SINTETICHE & AFFINI Como IT	CEP 2023-100 - Rev 00	Metoclopramide Hydrochloride monohydrate	2024-03-28	Valid	Chemical		674
29/11/2025	Icrom	Italy	ICROM S.R.L. Concorezzo IT	R1-CEP 2015-304 - Rev 00	Metoclopramide Hydrochloride monohydrate	2021-05-20	Valid	Chemical		674

Metoclopramide Hydrochloride Anhydrous

Metoclopramide hydrochloride anhydrous

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

26 API Suppliers

10 USDMF

4 CEP/COS

1 JDMF

3 EU WC

9 NDC API

15 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

17 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

120 FDF Dossiers

78 FDA Orange Book

9 Europe

10 Canada

4 South Africa

19 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, ORALLY DISINTEGRATING;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

5 Evonik

5 Rochem International Inc

18 SPI Pharma

6 DKSH

5 Boai NKY Pharmaceuticals Ltd

7 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

1 Pfanstiehl

4 Kirsch Pharma

4 ACG Worldwide

6 Actylis

1 Alcedo Pharmachem

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

17 BASF

1 CD Formulation

2 Corel Pharma Chem

6 DFE Pharma

1 Finar

7 Gangwal Chemicals

1 Ideal Cures

4 Ingredion Pharma Solutions

15 Kerry

2 Keval Exports

3 Lonza Capsugel

16 Microlex e.U

2 Nitika Pharmaceutical Specialities

2 Novo Excipients

4 Pharmatrans-Sanaq

6 Pluviaendo

3 Prachin Chemical

1 Qualicaps

28 Roquette

1 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

9 Sigachi Industries

3 Silverline Chemicals

1 Ulanqab Kema New Material

2 Valens Pharmachem

3 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

72 Fillers, Diluents & Binders

41 Direct Compression

34 Disintegrants & Superdisintegrants

30 Taste Masking

28 Granulation

INJECTABLE;INJECTION - EQ 5MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, ORALLY DISINTEGRATING;ORAL - EQ 10MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons